AVALIAÇÃO DAS ATIVIDADES ANGIOGÊNICA, MUTAGÊNICA E ANTIMUTAGÊNICA DA SOLUÇÃO AQUOSA DA Tabebuia impetiginosa (Ipê roxo).

Abstract

Brazil has the worlds largest plant genetic diversity, with cataloging more than 55.000 species between an estimated 350-550 thousand, already in equivalence only 8% of the national flora was studied among these plants 1.100 were related to their properties medicinal. Among the many medicinal plants used in Brazil, is Tabebuia impetiginosa, popularly known as purple Ipe, typical of the Brazilian cerrado, and has anti-inflammatory, analgesic, antibiotic and anti-neoplastic. The most studied and constituent responsible for pharmacological activities of purple Ipe, as described in the literature is Lapachol. Based on the characteristics of the aqueous solution of purple ipe, the aim of this study was to evaluate its potential angiogenic, mutagenic and antimutagenic activity by testing the chorioallantoic membrane (MCA) and micronucleus in hematopoietic bone marrow of mice. The chemotherapy mitomycin (MMC), known for its mutagenic effect, was used as positive control. The results showed an increase of angiogenesis in vascular network (p<0.05) compared to the MCAs negative controls (p<0.05) and inhibitor (p<0.05) when using aqueous purple ipe at a concentration of 10 mg(ml). In the micronucleus test, it was observed that the aqueous solution of purple ipe at doses of 10, 20 and 30 mg (b.w.), showed no mutagenic activity and no protective effect on the genotoxicity induced by MMC.